Colgate-Palmolive (NYSE: CL) revenue
Colgate-Palmolive reported revenue of $20,382m for fiscal 2025, 1.4% more than in fiscal 2024 ($20,101m). Since fiscal 2016 its revenue has grown by 34.1%, an average growth of 3.3% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $20,382m | +1.4% | $3,306m | 16.2% |
| 2024 | $20,101m | +3.3% | $4,268m | 21.2% |
| 2023 | $19,457m | +8.3% | $3,984m | 20.5% |
| 2022 | $17,967m | +3.1% | $2,893m | 16.1% |
| 2021 | $17,421m | +5.8% | $3,332m | 19.1% |
| 2020 | $16,471m | +5.0% | $3,885m | 23.6% |
| 2019 | $15,693m | +1.0% | $3,554m | 22.6% |
| 2018 | $15,544m | +0.6% | $3,694m | 23.8% |
| 2017 | $15,454m | +1.7% | $3,707m | 24.0% |
| 2016 | $15,195m | — | $3,955m | 26.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Colgate-Palmolive
- How much revenue did Colgate-Palmolive make in fiscal 2025?
- Colgate-Palmolive reported revenue of $20,382m for fiscal 2025, compared with $20,101m in fiscal 2024.
- How much has the revenue of Colgate-Palmolive grown?
- Between fiscal 2016 and fiscal 2025 it went from $15,195m to $20,382m: 34.1% more, an average growth of 3.3% a year.
- What was the best year for revenue at Colgate-Palmolive?
- Of its last 10 fiscal years, fiscal 2025, with $20,382m.
- Where do the figures for Colgate-Palmolive come from?
- From the annual report (Form 10-K) that Colgate-Palmolive files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Colgate-Palmolive files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Colgate-Palmolive: the Colgate-Palmolive page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.